Back to Search
JASMINE GHUMAN, MD
MD
Internal Medicine Physician
NPI: 1558914465IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A176699(CA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2011
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Ketorolac and morphine for analgesia in acute renal colic: is this combination more effective than monotherapy?
PMID 18226320·CJEM·2008
8-other
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
PMID 17979578·J Child Adolesc Psychopharmacol·2007
4-observational
Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
PMID 17023870·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).
PMID 17023869·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Stimulant-related reductions of growth rates in the PATS.
PMID 17023868·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
PMID 17023867·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Safety and tolerability of methylphenidate in preschool children with ADHD.
PMID 17028508·J Am Acad Child Adolesc Psychiatry·2006
4-observational
Structural basis of the drug-binding specificity of human serum albumin.
PMID 16169013·J Mol Biol·2005
8-other
Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder.
PMID 19364293·J Child Adolesc Psychopharmacol·2009
8-other
Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.
PMID 18752063·J Autism Dev Disord·2009
2-rct
Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice.
PMID 18844482·J Child Adolesc Psychopharmacol·2008
6-review
Crystallographic analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXalpha.
PMID 18602119·J Mol Biol·2008
8-other
Cognitive effects of risperidone in children with autism and irritable behavior.
PMID 18582177·J Child Adolesc Psychopharmacol·2008
4-observational
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
PMID 17979579·J Child Adolesc Psychopharmacol·2007
2-rct
Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
PMID 17979583·J Child Adolesc Psychopharmacol·2007
8-other
Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
PMID 17979582·J Child Adolesc Psychopharmacol·2007
8-other
Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
PMID 17979581·J Child Adolesc Psychopharmacol·2007
4-observational
Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
PMID 17979580·J Child Adolesc Psychopharmacol·2007
8-other
Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
PMID 17979577·J Child Adolesc Psychopharmacol·2007
4-observational
A prospective open trial of guanfacine in children with pervasive developmental disorders.
PMID 17069547·J Child Adolesc Psychopharmacol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Quick Facts
- NPI
- 1558914465
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 15
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile